United States - English - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - terazosin hydrochloride (unii: d32s14f082) (terazosin - unii:8l5014xet7) - terazosin 1 mg - terazosin capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (bph). there is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of bph when treated with terazosin capsules. the long-term effects of terazosin capsules on the incidence of surgery, acute urinary obstruction or other complications of bph are yet to be determined. terazosin capsules are also indicated for the treatment of hypertension. terazosin capsules can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents. terazosin capsules are contraindicated in patients known to be hypersensitive to terazosin hydrochloride.

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - terazosin hydrochloride (unii: d32s14f082) (terazosin - unii:8l5014xet7) - terazosin 5 mg - terazosin capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (bph). there is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of bph when treated with terazosin capsules. the long-term effects of terazosin capsules on the incidence of surgery, acute urinary obstruction or other complications of bph are yet to be determined. terazosin capsules are also indicated for the treatment of hypertension. terazosin capsules can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents. terazosin capsules are contraindicated in patients known to be hypersensitive to terazosin hydrochloride.

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - terazosin hydrochloride dihydrate 1.19mg equivalent to 1 mg terazosin;   - tablet - 1 mg - active: terazosin hydrochloride dihydrate 1.19mg equivalent to 1 mg terazosin   excipient: lactose monohydrate magnesium stearate maize starch purified talc - terazosin tablets are indicated for the symptomatic and pathophysiologic treatment of benign prostatic hyperplasia (bph) when: - prostatectomy is not indicated - patient is not fit for surgery - elective surgery must be postponed (e.g., waiting list) - patient refuses surgical treatment. terazosin is also indicated in the treatment of hypertension. it can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents.

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - terazosin hydrochloride dihydrate 2.38mg equivalent to 2 mg terazosin;   - tablet - 2 mg - active: terazosin hydrochloride dihydrate 2.38mg equivalent to 2 mg terazosin   excipient: lactose monohydrate magnesium stearate maize starch purified talc quinoline yellow - terazosin tablets are indicated for the symptomatic and pathophysiologic treatment of benign prostatic hyperplasia (bph) when: - prostatectomy is not indicated - patient is not fit for surgery - elective surgery must be postponed (e.g., waiting list) - patient refuses surgical treatment. terazosin is also indicated in the treatment of hypertension. it can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents.

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - terazosin hydrochloride dihydrate 5.95mg equivalent to 5 mg terazosin;   - tablet - 5 mg - active: terazosin hydrochloride dihydrate 5.95mg equivalent to 5 mg terazosin   excipient: iron oxide red lactose monohydrate magnesium stearate maize starch purified talc - terazosin tablets are indicated for the symptomatic and pathophysiologic treatment of benign prostatic hyperplasia (bph) when: - prostatectomy is not indicated - patient is not fit for surgery - elective surgery must be postponed (e.g., waiting list) - patient refuses surgical treatment. terazosin is also indicated in the treatment of hypertension. it can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents.

United States - English - NLM (National Library of Medicine)

jubilant cadista pharmaceuticals inc. - terazosin hydrochloride (unii: d32s14f082) (terazosin - unii:8l5014xet7) - terazosin 1 mg - terazosin capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (bph). there is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of bph when treated with terazosin capsules. the long-term effects of terazosin capsules on the incidence of surgery, acute urinary obstruction or other complications of bph are yet to be determined. terazosin capsules are also indicated for the treatment of hypertension. terazosin capsules can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents. terazosin capsules are contraindicated in patients known to be hypersensitive to terazosin hydrochloride.

United States - English - NLM (National Library of Medicine)

state of florida doh central pharmacy - terazosin hydrochloride (unii: d32s14f082) (terazosin - unii:8l5014xet7) - terazosin 1 mg - terazosin capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (bph). there is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of bph when treated with terazosin capsules. the long-term effects of terazosin capsules on the incidence of surgery, acute urinary obstruction or other complications of bph are yet to be determined. terazosin capsules are also indicated for the treatment of hypertension. terazosin capsules can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents. terazosin capsules are contraindicated in patients known to be hypersensitive to terazosin hydrochloride.

United States - English - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - terazosin hydrochloride (unii: d32s14f082) (terazosin - unii:8l5014xet7) - terazosin 2 mg - terazosin capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (bph). there is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of bph when treated with terazosin capsules. the long-term effects of terazosin capsules on the incidence of surgery, acute urinary obstruction or other complications of bph are yet to be determined. terazosin capsules are also indicated for the treatment of hypertension. terazosin capsules can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents. terazosin capsules are contraindicated in patients known to be hypersensitive to terazosin hydrochloride.

United States - English - NLM (National Library of Medicine)

proficient rx lp - terazosin hydrochloride (unii: d32s14f082) (terazosin - unii:8l5014xet7) - terazosin 10 mg - terazosin capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (bph). there is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of bph when treated with terazosin capsules. the long-term effects of terazosin capsules on the incidence of surgery, acute urinary obstruction or other complications of bph are yet to be determined. terazosin capsules are also indicated for the treatment of hypertension. terazosin capsules can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents. terazosin capsules are contraindicated in patients known to be hypersensitive to terazosin hydrochloride.

United States - English - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - terazosin hydrochloride anhydrous (unii: 8qop8z9955) (terazosin - unii:8l5014xet7) - terazosin 2 mg - terazosin capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (bph). there is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of bph when treated with terazosin capsules. the long-term effects of terazosin capsules on the incidence of surgery, acute urinary obstruction or other complications of bph are yet to be determined. terazosin capsules are also indicated for the treatment of hypertension. it can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents. terazosin capsules are contraindicated in patients known to be hypersensitive to terazosin hydrochloride.